Skip to main content
Log in

Pharmacokinetics of albendazole in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The pharmacokinetics of albendazole were investigated in healthy volunteers and in patients receiving albendazole for treatment of hydatid disease. Unchanged albendazole was below detectable limits in plasma, urine, bile and cyst fluid. The major metabolite present in all fluids was the sulfoxide. Maximum concentrations of albendazole sulfoxide in plasma were very variable, probably due to variable absorption of albendazole.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Marriner SE, Bogan JA (1980) Pharmacokinetics of albendazole in sheep. Am J Vet Res 41: 1126–1129

    Google Scholar 

  2. Gyurik RJ, Chow AW, Zaber B, Brunner EL, Miller JA, Villani AJ, Petka LA, Parish RC (1981) Metabolism of albendazole in cattle, sheep, rats and mice. Drug Metab Dispos 9: 503–508

    Google Scholar 

  3. Morris DL, Dykes PW, Dickson B, Marriner SE, Bogan JA, Burrows FGO (1983) Albendazole in hydatid disease. Br Med J 286: 103–104

    Google Scholar 

  4. Munst GJ, Karlanganis G, Bircher J (1980) Plasma concentrations of mebendazole during treatment of Echinococcosis. Eur J Clin Pharmacol 17: 375–378

    Google Scholar 

  5. Bogan JA, Marriner SE (1980) Analysis of benzimidazoles in body fluids by high performance liquid chromatography J Pharm Sci 69: 422–423

    Google Scholar 

  6. Bryceson ADM, Woestenborghs R, Michiels M, Van Den Bossche H (1982) Bioavailability and tolerability of mebendazole in patients with inoperable hydatid disease. Trans R Soc Trop Med Hyg 76: 563–564

    Google Scholar 

  7. Morris DL, Gould SE (1982) Serum and cyst concentrations of mebendazole and flubendazole in hydatid disease. Br Med J 285: 175–179

    Google Scholar 

  8. Witassek F, Burkhardt B, Eckert J, Bircher J (1981) Chemotherapy of alveolar echinococcosis. Eur J Clin Pharmacol 20: 427–433

    Google Scholar 

  9. Braithwaite PA, Roberts MS, Allan RJ, Watson TR (1982) Clinical pharmacokinetics of high dose mebendazole in patients treated for cystic hydatid disease. Eur J Clin Pharmacol 22: 161–169

    Google Scholar 

  10. Meuldermans WEG, Hurkmans RMA, Lauwers WFJ, Heykants JJP (1976) The in vitro metabolism of mebendazole by pig, rat and dog liver fractions. Eur J Drug Metab Pharmacokinet 1: 35–40

    Google Scholar 

  11. Luder PJ, Witassek F, Weigand K, Eckert J, Bircher J (1985) Treatment of cystic echinococcosis(Echinococcus granulosus) with mebendazole. Assessment of bound and free drug levels in cyst fluid and of parasite vitality in operative specimens. Eur J Clin Pharmacol 28: 279–285

    Google Scholar 

  12. Waring RM, Mitchell SC, Shah RR, Idle JR, Smith RL (1982) Polymorphic sulphoxidation of S-carboxylmethyl-l-cysteine in man. Biochem Pharmacol 31: 3151–3154

    Google Scholar 

  13. Dawson M, Watson TR (1985) The effect of dose form on the bioavailability of mebendazole in man. Br J Clin Pharmacol 19: 87–90

    Google Scholar 

  14. Theodorides VJ, Nawalinski T, Chang J (1976) Efficacy of albendazole against gastrointestinal nematodes of cattle. Am J Vet Res 37: 1517–1518

    Google Scholar 

  15. Theodorides VJ, Nawalinski T, Chang J (1976) Efficacy of albendazole againstHaemonchus Nematodirus Dictyocaulus andMonezia of sheep. Am J Vet Res 37: 1515–1516

    Google Scholar 

  16. Rossignol JF, Couland JP (1982) Proceedings of Symposium; Albendazole in Helminthiasis, Nairobi, June 1982. R Soc Med 57: 19–25

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marriner, S.E., Morris, D.L., Dickson, B. et al. Pharmacokinetics of albendazole in man. Eur J Clin Pharmacol 30, 705–708 (1986). https://doi.org/10.1007/BF00608219

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00608219

Key words

Navigation